Our Approach to Care
Holistic and Comprehensive Care
We recognize that every child with a rheumatic condition is unique. We take a holistic approach to care that considers the entire patient, including their physical, emotional, and social factors. We strive to partner with patients and families in shared decision-making, empowering them with knowledge, support, and the most effective treatment options to achieve the best possible outcome for every child.
A Multidisciplinary Team Approach
Our pediatric rheumatologists work closely with specialists in other fields. We have access to NewYork-Presbyterian's network of specialists, including all areas of pediatric medicine, allowing us to provide state-of-the-art, comprehensive, and coordinated care for any medical issue or concern.
Parents As Team Members
As a parent, only you can provide important information about your child. You can also help other team members shape your child's personalized treatment program based on your child's physical, emotional, and practical needs. Your input is critical for making final decisions regarding your child's care. Our multidisciplinary team is here to work alongside you and your family to achieve your child's best possible outcomes.
How We Diagnose Rheumatic Conditions
Our initial comprehensive evaluation includes thorough patient history, physical examination, and detailed review of previous records and test results.
To test for rheumatic conditions we may perform immunological and autoimmunologic testing. Depending on the condition, we may perform additional specialized procedures, laboratory testing, and consultation with specialists in other fields such as gastroenterology, pulmonology, hematology-oncology, immunology, endocrinology, and genetics.
Our pediatric rheumatologists work with patients and families to create comprehensive diagnostic and treatment plans.
Treatment and Monitoring
With proper treatment and monitoring, many rheumatic conditions in children can be managed. Our patients have access to the latest medications and therapies and a range of specialists at the Children's Hospital of New York. We provide guidance and support to patients and their families throughout the treatment process, along with ongoing monitoring and care.
Special programs
Pediatric AMPS Clinic
At NewYork-Presbyterian Morgan Stanley Children's Hospital, the Pediatric Amplified Musculoskeletal Pain Syndrome (AMPS) Clinic provides expert evaluation and compassionate care for children and adolescents with AMPS. This condition is characterized by chronic pain in the muscles, joints, or other parts of the body, which occurs without any underlying injury or inflammation. The Pediatric AMPS Clinic accurately diagnoses this challenging condition and helps your family through the treatment process.
Kawasaki Disease Program
At NewYork-Presbyterian Morgan Stanley Children's Hospital, the Kawasaki Disease Program provides expert, comprehensive care for children with Kawasaki disease. Kawasaki disease is a condition that causes inflammation of blood vessels and tissues throughout the body. It occurs most often in children under the age of five. If not treated early, it can cause temporary or permanent damage to the coronary artery, the blood vessel that supplies oxygen to the heart. Most children recover fully from this disease.
CRMO Disease Program
At NewYork-Presbyterian Komansky Children's Hospital & through Weill Cornell Medicine's affiliation with the Hospital for Special Surgery, the CRMO program provides expert, comprehensive care for children with non-infectious osteomyelitis. CRMO causes inflammation within bones.
Time to diagnosis is often delayed leading to bone destruction and pain. The CRMO program can help to provide a quicker road to treatment, reduce unnecessary testing and ensure the best outcome possible. Collaboration with orthopedics, GI, and dermatology leads to seamless care
Scleroderma Program
The Scleroderma program at NewYork-Presbyterian Komansky Children's Hospital provides expert, comprehensive care for children with scleroderma. The program brings novel therapeutics and care to children with scleroderma, whether limited or diffuse.